Predicting Thyroid Cancer Recurrence Using Machine Learning: An Artificial Intelligence Approach to Clinical Oncology
International Journal of Advances in Artificial Intelligence and Machine Learning · 2025
DOI: 10.58723/ijaaiml.v2i3.469 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advances in Artificial Intelligence and Machine Learning, 2025. Verfasst von Joy Aifuobhokhan und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background of study: Differentiated thyroid cancer (DTC) accounts for most thyroid malignancies and has favorable survival outcomes, yet up to 30% of patients experience recurrence, placing strain on follow-up systems in resource-limited settings. Conventional staging tools offer limited predictive precision. With increasing interest in machine learning (ML) for precision oncology, there is a need for interpretable, deployable models suitable for low-resource environments.Aims and scope of paper: To develop and validate an interpretable machine learning model for predicting thyroid cancer recurrence and assess its feasibility for deployment in constrained clinical settings, including African oncology contexts.
Methods
A retrospective dataset of 383 DTC patients with at least 10-year follow-up was sourced from the UCI Machine Learning Repository. Thirteen demographic, clinical, and treatment-related predictors were included. Data preprocessing involved encoding, scaling, and class balancing using SMOTE. Logistic Regression, Random Forest, K-Nearest Neighbors, and Extreme Gradient Boosting (XGBoost) were trained with hyperparameter tuning via grid search and cross-validation. Performance was evaluated using accuracy, precision, recall, F1 score, and AUC-ROC.
Result
XGBoost achieved the best performance with 97% accuracy, 95% recall, 94% precision, and an AUC-ROC of 0.93. The most influential predictors were age, smoking status, T and M staging, ATA risk category, and adenopathy. The final model was deployed as a browser-based decision support tool to enable real-time recurrence risk estimation.
Conclusion
This study presents a high-performing and interpretable ML model for predicting DTC recurrence, demonstrating feasibility for use in low-resource oncology settings. External validation with African clinical datasets and integration into electronic health systems is recommended to enhance equity and clinical uptake.
Zitieren
APA
Aifuobhokhan, J., Hussain, A. K., Ekechi, C. C., Olanrewaju, A. O., Afuadajo, E., Bowale, D. A., & Inioluwa, O. M. (2025). Predicting Thyroid Cancer Recurrence Using Machine Learning: An Artificial Intelligence Approach to Clinical Oncology. International Journal of Advances in Artificial Intelligence and Machine Learning. https://doi.org/10.58723/ijaaiml.v2i3.469
Vancouver
Aifuobhokhan J, Hussain AK, Ekechi CC, Olanrewaju AO, Afuadajo E, Bowale DA, et al. Predicting Thyroid Cancer Recurrence Using Machine Learning: An Artificial Intelligence Approach to Clinical Oncology. International Journal of Advances in Artificial Intelligence and Machine Learning. 2025. doi:10.58723/ijaaiml.v2i3.469
BibTeX
@article{Aifuobhokhan2025,
author = {Aifuobhokhan, Joy and Hussain, Ahmad Khalid and Ekechi, Chijioke Cyriacus and Olanrewaju, Aisha Olasunbo and Afuadajo, Emmanuel and Bowale, Deborah Adetola and Inioluwa, Oluwadare Marvellous},
title = {Predicting Thyroid Cancer Recurrence Using Machine Learning: An Artificial Intelligence Approach to Clinical Oncology},
journal = {International Journal of Advances in Artificial Intelligence and Machine Learning},
year = {2025},
doi = {10.58723/ijaaiml.v2i3.469}
}
EUVIMED